地址:XiongCounty of Hebei province
联系人:温长路
电话:0312-5761277
手机:13932255438
邮箱:quansheng@china-qsh.com
传真:0312-5765789
点击这里给我发送消息 点击这里给我发送消息
当前位置:首页 > News > 公司新闻
Over the next 10 years the world development trend of pharmaceutical packaging
发布时间:2015-1-24 15:22:46 点击次数:

Pressure comes from the new end user, legislation and regulations and the pharmaceutical industry is increasingly fierce competition. Over the next decade, as pharmaceutical companies started production for small scale medicines, packaging company will have to take corresponding measures, for example, provides a small number of highly specialized packaging system. Population decline, the change of the medical care payment, finance, product trend of adjustment will also be in the future 10 years continuous impact on packing. Experts predict that only those who introduce new packaging platform, efforts to meet the needs of packaging industry innovators these trends to become the market leader. However, small companies will benefit from the biological products and the emergence of personalized medicine, they will also usher in a new market opportunity, if we can seize the opportunity, small businesses are promising. Multiple factors A growing number of elderly population will have an important influence on the packing of the drugs for the future. Exercise capacity loss, decreased muscle strength, visually impaired, this series of the human body function decline and ageing will directly affect the design and manufacture of pharmaceutical packaging. The old memory decline, but every day to take a lot of drugs, it is the important factor causing medication errors. Packaging design also need to consider the situation. To meet the growing elderly market at the same time, drug packaging industry must also meet the requirements of the children. In preventing medication errors and improve the adaptability, the packaging must be play an important role. Packaging industry is being from both government and private stakeholders is more and more big pressure, they are required to improve the packing, in order to reduce medication errors. In November 2000, the United States food and drug administration (FDA) has proposed a new prescription drug markup format. On April 18, 2001, the U.S. labor department, the office of occupational safety and health (OSHA) has revised the blood infectious source control standards, choose our safety needle equipment set up more requirements. In June 2001, NCCMERP medication error reporting (country) and prevention coordination committee recommended on drug use the standard bar code, in order to reduce errors and improve patient care. Just two years, a series of regulation puts forward new requirements for drug packaging. Biotech drugs and packaging interactional effect more apparent. With the increase of number of biological medicine, and the international coordination of regulations will lead to the high standards for biological drugs, adjustment of biological pharmaceutical packaging review are also on the increase. In short, the new regulatory requirements safer pharmaceutical products, to protect the child's medicine packing and stricter guidelines, these requirements as well as more complex medicines, such as biological pharmaceutical packaging, for packaging in keeping the product with low price, offer innovative product solutions. There are boundless opportunities in the future for now, the $15 billion worldwide pharmaceutical packaging industry has presented historically low growth. However, in the next ten years, the change of drug types and their packaging requirements for packaging market expansion of provides a new opportunity, which include: container components manufactured by the new material and coating, improve flexibility and reduce medication errors packaging systems (such as blister packaging), biological pharmaceutical packaging overall solution, combined diagnosis/drug packaging, etc. In this decade, will produce a more global packaging company, the company is able to provide low-cost worldwide packaging services, will also be able to meet the needs of the future biological pharmaceutical packaging.


In the next decade the inner packing, the expansion of the market there are several ways to is expected to expand the market share of company should have the following features:

Low to provide comprehensive business services, including biological pharmaceutical packaging. These companies will benefit from this part of the rapid growth of pharmaceutical products.

Take packaging innovation, satisfy the new packaging requirements, and keep the current price level.

Like those customers global pharmaceutical company, a global packaging company. Most capable of these companies on a global scale according to the customer's requirements, to take effective and efficient measures.

For just a personalized medicine market, the development can be used in different areas of high cost effectiveness of packaging services.

Second-ranking keep big customer. Competition in the pharmaceutical industry restructuring reduce the total number of customers, but the importance of the big customer is thus increased.